-
Rebecca Robbins and Pam Belluck
Posts
Alzheimer’s Drug Slows Cognitive Decline in Key Study
Biogen and Eisai reported the finding from a large late-stage clinical trial of lecanemab, a drug they are developing.
Rebecca Robbins and Pam Belluck